Safety and Efficacy of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052)

Clinical trial NCT02092350 · COMPLETED

Trial details

NCT number: NCT02092350
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hepatitis C Virus

Start date: 2014-03-17
Primary completion: 2015-03-11
Enrollment: 237

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.